FPAS
RLAY icon

Focus Partners Advisor Solutions’s Relay Therapeutics RLAY Stock Holding History

Focus Partners Advisor Solutions’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,631
Closed -$115K – 1392
2026
Q1 		$115K Buy
11,631
+966
+9% +$8.64K ﹤0.01% 1196
2025
Q4 		$90.2K Sell
10,665
-260
-2% -$1.85K ﹤0.01% 1057
2025
Q3 		$63.2K Sell
10,925
-237
-2% -$904 ﹤0.01% 1111
2025
Q2 		$38.6K Buy
+11,162
New +$33.2K ﹤0.01% 1080

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Focus Partners Advisor Solutions's RLAY Position: Q2 2026 in Review

Focus Partners Advisor Solutions sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 11,631 shares — an estimated $115K sold.

Focus Partners Advisor Solutions first reported a position in RLAY in Q2 2025 and held it in 4 quarters. The position peaked at $115K in Q1 2026. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Focus Partners Advisor Solutions reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 11,631 Relay Therapeutics shares in Q2 2026, an estimated $115K.
  • Focus Partners Advisor Solutions first reported a position in Relay Therapeutics in Q2 2025 and held it in 4 quarters.
  • Focus Partners Advisor Solutions's Relay Therapeutics position peaked at $115K in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.